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        Introduction 
 Endothelial cells (ECs) line vessel walls and control the transition 
of water and plasma proteins between blood and the underlying 
tissue. Endothelial barrier function depends on interendothelial 
junctions (IEJs), and defective sealing of cell  –  cell contacts in-
creases paracellular leakage that may result in edema formation 
(  Dejana, 2004  ). Control of perijunctional actin assembly ap-
pears to be the unifying mechanism for regulating endothelial 
junctions and paracellular permeability (  Mitic and Anderson, 
1998  ;   Mehta and Malik, 2006  ). 
  Members of the Enabled/vasodilator-stimulated phospho-
protein (Ena/VASP) protein family are involved in cortical actin 
dynamics, although their exact function for cytoskeletal regulation 
remains unclear (  Vasioukhin et al., 2000  ;   Scott et al., 2006  ). 
In mammals, the Ena/VASP family consists of the following three 
proteins: mammalian Ena (Mena), VASP, and Ena-VASP  –  like 
(EVL). The family members share a tripartite domain organiza-
tion of an N-terminal Ena/VASP homology 1 (EVH1) domain, a 
central proline-rich region (PRR), and an EVH2 domain at the 
C terminus (  Kwiatkowski et al., 2003  ;   Sechi and Wehland, 2004  ). 
The EVH1 domain mediates binding of Ena/VASP proteins to 
proline-rich ligands such as vinculin and zyxin (  Ball et al., 2000  ). 
The PRR interacts with the actin-binding protein profi  lin and 
with Src homology 3 (SH3) domains (  Lambrechts et al., 2000  ; 
  Howe et al., 2002  ), whereas the EVH2 domain mediates tetra-
merization and actin binding ( Bachmann et al., 1999 ;  Kuhnel et al., 
2004  ). VASP harbors three serine/threonine phosphorylation 
sites. S157 is located N-terminally of the central PRR. S239 and 
T278 are within the EVH2 domain, adjacent to the G- and F-actin 
binding sites, respectively (  Kwiatkowski et al., 2003  ). In vivo, S157 
is preferentially phosphorylated by the cAMP-dependent protein 
kinase (PKA), whereas S239 and T278 are targeted by the cGMP-
dependent protein kinase (PKG) or the AMP-activated protein 
kinase (AMPK), respectively ( Blume et al., 2007 ). Phosphorylation 
of VASP regulates its affi  nity for F-actin ( Lambrechts et al., 2000 ; 
  Barzik et al., 2005  ) and SH3 domains (  Howe et al., 2002  ). 
  D
irected cortical actin assembly is the driving force 
for intercellular adhesion. Regulated by phos-
phorylation, vasodilator-stimulated phosphoprotein 
(VASP) participates in actin ﬁ  ber formation. We screened 
for endothelial proteins, which bind to VASP, depen  dent 
on its phosphorylation status. Differential proteomics 
identiﬁ  ed     II-spectrin as such a VASP-interacting protein. 
    II-Spectrin binds to the VASP triple GP  5 -motif via its SH3 
domain. cAMP-dependent protein kinase  –  mediated VASP 
phosphorylation at Ser157 inhibits     II-spectrin  –  VASP 
binding. VASP is dephosphorylated upon formation of 
cell  –  cell contacts and in conﬂ  uent, but not in sparse cells, 
    II-spectrin colocalizes with nonphosphorylated VASP 
at cell  –  cell junctions. Ectopic expression of the     II-spectrin 
SH3 domain at cell  –  cell contacts translocates VASP, initi-
ates cortical actin cytoskeleton formation, stabilizes cell  –
  cell contacts, and decreases endothelial permeability. 
Conversely, the permeability of VASP-deﬁ  cient endothelial 
cells (ECs) and microvessels of VASP-null mice increases. 
Reconstitution of VASP-deﬁ  cient ECs rescues barrier func-
tion, whereas     II-spectrin binding-deﬁ  cient VASP mutants 
fail to restore elevated permeability. We propose that 
    II-spectrin  –  VASP complexes regulate cortical actin cytoskel-
eton assembly with implications for vascular permeability.
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dent on its phosphorylation status. VASP pseudophosphorylation 
mutants VASP-DDE and -AAA (which mimic completely phos-
phorylated or unphosphorylated protein, respectively) were 
expressed in   Escherichia coli ,  purifi  ed, and linked to an affi  nity 
chromatography matrix. Cytosolic proteins from confl  uent 
EA.hy926 ECs were applied to columns with immobilized VASP 
mutants. Specifi  cally bound proteins were eluted by a pH gradient. 
We probed the eluates for known VASP-interacting proteins 
and detected zyxin and vinculin in the pH 2.0 fraction by Western 
blotting. Proteins of this fraction were analyzed using 2D-PAGE. 
Colloidal Coomassie blue staining detected   >  100 VASP-binding 
proteins in the eluates of VASP-DDE and -AAA columns, respec-
tively (representative 2D gels from   n   = 6;   Fig. 1  , compare A, B, 
and the merged image C). A protein spot with apparent molecular 
weight of   >  200 kD was eluted from VASP-AAA, but not from 
VASP-DDE ( Fig. 1, A ’  and B ’  ). Using matrix-assisted laser desorp-
tion ionization time-of-fl  ight (MALDI-TOF) peptide mass fi  nger-
printing (PMF), we identifi  ed the protein as    II-spectrin  (SPCN; 
mascot score of 257; National Center for Biotechnology Infor-
mation sequence identifi  cation number gi|31565122;   Fig. 1 D  ).
The calculated pI of 5.2 and molecular weight of 240 kD of SPCN 
is consistent with the observed migration behavior in the 2D gel. 
  VASP interacts with SPCN at sites of 
interendothelial adhesion 
 To confi  rm the interaction of SPCN and VASP, confl  uent EA.hy926 
cells were lysed, immunoprecipitated with antibodies against 
 Originally  identifi  ed in erythrocytes, spectrins are evolution-
ary conserved rod-shaped proteins that associate with   actin fi  la-
ments to form a 2D meshwork at the cytoplasmic face of the plasma 
membrane. Spectrins exist as heterotetramers (   ,    ) 2  , composed of 
     and      subunits, which show distinct functions and tissue-specifi  c 
expression (  Bennett and Baines, 2001  ). The    II-spectrin  subunit 
(also known as SPCN,     -  fodrin, and nonerythroid    -spectrin)  is 
ubiquitously expressed (except erythrocytes) and predominantly 
exists as    II/   II   tetramers (  Heltianu et al., 1986  ). Spectrins are 
scaffolders and assemble a multifunctional interface that links 
membranes to fi  laments of the perijunctional cytoskeleton 
(  De Matteis and Morrow, 2000  ). Spectrins cluster transmembrane 
ad  hesion proteins within plasma membrane microdomains and 
couple them to the spectrin – actin network on both sites of the junc-
tion (  De Matteis and Morrow, 2000  ;   Pinder and Baines, 2000  ). 
  In this study, we identifi  ed     II-spectrin as a new VASP-
binding protein and characterized structure, regulation, and 
function of     II-spectrin interaction with VASP with importance 
for endothelial cell  –  cell adhesion and vascular permeability. 
  Results 
         II-Spectrin (SPCN) is a new VASP-binding 
protein in ECs 
  VASP is phosphorylated by PKA, PKG, and AMPK at residues 
S157, S239, and T278, respectively. We used differential pro-
teomics to identify endothelial proteins that bind to VASP depen-
  Figure 1.            II-Spectrin (SPCN) is a new VASP-binding protein in ECs.   Proteins that bind to VASP dependent on its phosphorylation status were isolated from 
EA.hy926 cell cytosol by afﬁ  nity chromatography columns with coupled VASP-DDE (orange) or -AAA (blue). Eluted proteins were separated by 2D-PAGE 
and stained with colloidal Coomassie (A and B). (C) Merged and magniﬁ  ed image of areas indicated by dashed boxes in A and B. Black spots represent 
proteins that bind to both VASP forms. The boxed spot marks     II-spectrin (SPCN). (A     and B    ) Magniﬁ  cation of the SPCN spot in B and the corresponding 
gel area in A (top), and 3D densitograms of the signal intensities (bottom). (D) MALDI-PMF spectrum of the spot in B     identiﬁ  ed SPCN. Annotated peaks 
represent identiﬁ  ed peptides, which are labeled with the exact mass (bold letters) and the amino acid positions of the protein. Peaks marked with asterisks 
represent trypsin-fragments, which originate from autodigestion of the protease.     207 FORMATION OF CORTICAL ACTIN CYTOSKELETONS   •   BENZ ET AL.
et al., 1999 ), we analyzed SPCN SH3 domain (SPCN_SH3, resi-
dues E970 – D1025) binding to VASP. SPCN_SH3 was cloned, 
expressed as a GST-fusion protein, and used in pull-down experi-
ments. SPCN_SH3 (but not GST alone) precipitated VASP from 
cell lysates of confl  uent EA.hy926 and ECV304 (  Fig. 3 A  ). 
We used immortalized ECs from microvessels of VASP-null 
(EC-VASP 
 – / –   ) and wild-type mice (EC-VASP 
+/+ ).  A  VASP  signal 
was only detected in SPCN_SH3 precipitates from EC-VASP 
+/+  
mice, confi  rming the specifi  city of anti-VASP antibodies ( Fig. 3 B ). 
To exclude that VASP binding to SPCN_SH3 is indirect, we 
analyzed purifi  ed recombinant proteins in a cell-free system. 
SPCN_SH3 specifi  cally precipitated VASP (  Fig. 3 D  , left lanes). 
 SH3 domains are versatile protein interaction modules, which 
bind to proline-rich ligands with moderate affi  nity and selectiv-
ity (  Mayer, 2001  ). To analyze the specifi  city of VASP binding to 
SPCN_SH3, we compared VASP binding to SPCN-related SH3 
domains that were selected with the SH3-SPOT algorithm. 
This algorithm predicts complex formation of VASP with SH3 
domains ranging from 0 (no affi  nity) to 1 (maximum affi  nity; 
  Brannetti et al., 2000  ). The N- and C-terminal SH3 domains of 
VAV1 (0.9075 and 0.8375), and the SH3 domains of Abl (0.8992) 
and SPCN (0.8916) had the highest score for VASP binding. 
VASP, and precipitated material was probed with anti-SPCN anti-
bodies or vice versa. Western blots indicated that SPCN and VASP 
mutually and specifi  cally immunoprecipitated each other (  Fig. 2, 
A and B ). Comparison of SPCN signal intensities in lysed cells and 
in immunodepleted lysate indicated that  > 70% of cellular SPCN 
was coprecipitated by VASP (  Fig. 2 B  , compare Lysate and 
Unbound), suggesting that the majority of the cellular SPCN pool 
is complexed with VASP in endothelial monolayers. SPCN  –  VASP 
interaction was further analyzed by confocal immunofl  uorescence 
microscopy in confl  uent ECV304 ECs (  Takahashi et al., 1990  ). 
VASP was localized at cell  –  cell contacts, stress fi  bers, and focal 
adhesion sites. In horizontal and vertical cell sections, VASP co-
localized with SPCN exclusively at cell  –  cell contacts, but not at 
focal adhesions or stress fi  bers ( Fig. 2 C, a – c ). Both proteins co-
localized with the tight junctions marker zonula occludens protein-1 
(ZO-1;   Fig. 2 C, d  –  i  ). SPCN and VASP colocalized at junctions in 
other ECs such as EA.hy926 and HUVEC (unpublished data). 
  The SPCN SH3 domain speciﬁ  cally and 
directly interacts with VASP 
  SPCN contains an SH3 domain (  Bennett and Baines, 2001  ). 
Because VASP binds to the SH3 domain of Abl (  Ahern-Djamali 
  Figure 2.       VASP interacts with SPCN at sites of inter-
endothelial adhesion.   (A and B) Lysates of conﬂ   uent 
EA.hy926 cells were immunoprecipitated (IP) with anti-
bodies against SPCN, VASP, or unrelated proteins (Control). 
Lysate, wash fraction (Wash), and precipitated material 
were analyzed by Western blot with anti-VASP (A) or -SPCN 
(B) antibodies. Cell lysate immunodepleted by anti-VASP 
antibodies and blotted for SPCN is shown in (B, Unbound). 
(C) Confocal immunoﬂ  uorescence images of ﬁ  xed and 
permeabilized ECV304 cells. Cells were stained for VASP 
(a and d), SPCN (b and g), and ZO-1 (e and h). Yellow 
color indicates colocalized VASP and SPCN (c), VASP 
and ZO-1 (f), and SPCN and ZO-1 (i). Insets on the right 
are confocal sections in the vertical plane of the Z-stacks, 
taken at the position of the dashed line. Arrows indicate 
sites of colocalization. Bar, 15     m.     JCB • VOLUME 180 • NUMBER 1 • 2008  208
PRR and the EVH2 domain (  Fig. 4 A  ). SPCN_SH3 precipitates 
from mutant-transfected 293 EBNA cells were analyzed with 
anti-VSV antibodies. VSV-VASP and VSV-EVH1-PRR, but not 
VSV-EVH1, bound to SPCN_SH3 (  Fig. 4 B  ), suggesting that 
the PRR mediates the VASP  –  SH3 domain interaction. To iden-
tify the SPCN_SH3 binding motif in the PRR, we used peptide 
scans (  Fig. 4 C  ). Overlapping, 15-aa-long peptides, spanning 
VASP PRR (residues 114  –  224) were synthesized on a cellulose 
membrane and incubated with SPCN_SH3 fused to GST or 
with GST alone (60 nM each). Bound proteins were detected by 
Western blotting with an anti-GST antibody. GST did not bind 
specifi  cally (not depicted). SPCN_SH3 interacted with peptides 
F2 (P 
165 PAGGPPPPPGPPPP 
179  ) and, more prominently, with 
F8 (P 
171 PPPGPPPPPGPPPP 
185  ;   Fig. 4 C  ). Both peptides overlap 
with the VASP triple GP  5   motif (positions 169  –  186). Peptides 
E10, F3, F4, and F10, which are as proline-rich as F8, were 
negative for SPCN_SH3 binding, confi  rming the specifi  city of 
the interaction. Peptides A1  –  A4, which cover the single GP  5   motif 
in the N-terminal portion of the PRR (G 
117 PPPPP 
122  ), did not 
bind to SPCN_SH3 (  Fig. 4 C  ). 
  VASP prolines 177, 178, and 179 are 
crucial for the SPCN  –  VASP interaction 
  To pinpoint residues within the VASP triple GP  5   motif that are 
crucial for SPCN binding, residues in F8 were systematically 
changed to alanine (  Fig. 4 D  ). Substitution of the prolines P171, 
P174, P182, P185, and glycines G175 and G181 did not affect 
SPCN_SH3  –  VASP binding. Exchange of P172, P173, P183, and 
P184 moderately decreased SH3 binding to VASP. In contrast, 
proline residues from the central GP  5   motif (P176-P180) were 
critical for SH3 binding and exchange of any of the residues 177, 
178, or 179 abrogated SPCN_SH3 binding (  Fig. 4 D  ). To evalu-
ate the importance of the three prolines for SH3 binding to full-
length VASP, we generated VASP point mutants (P177A, P178A, 
and P179A). P179A interaction with SH3 was weak compared 
with nonmutated VASP. Substitution of P177 or P178 completely 
abrogated VASP binding to SPCN_SH3 (  Fig. 4 E  ). To test the 
importance of the GP  5   motif for SPCN binding in cells, we re-
constituted EC-VASP 
 – / –    cells with His  6  -tagged wild-type VASP or 
P177A, P178A, and P179A. SPCN bound to wild-type VASP in 
coprecipitation experiments (positive control), but substitutions 
within the central GP  5   motif impaired SPCN binding (  Fig. 4 F  ). 
  PKA-mediated phosphorylation of VASP at 
S157 inhibits its interaction with SPCN 
  SPCN bound to VASP-AAA, but not to -DDE (  Fig. 1  ), suggesting 
that VASP phosphorylation controls the SPCN  –  VASP inter-
action. Because VASP residues P177-P179 are located in prox-
imity to the PKA phosphorylation site S157 ( Fig. 4 C ), we analyzed 
S157 phosphorylation for SPCN  –  VASP binding. Phosphorylation 
at S157 induces an electrophoretic mobility shift of the protein 
from 46 to 50 kD (  Krause et al., 2003  ). We incubated purifi  ed 
His  6  -tagged VASP with active PKA in vitro. Anti-VASP antibod-
ies detected the completely S157-phosphorylated protein at 50 kD 
(pS157-VASP;   Fig. 5 A  ). In our pull-down assay, SPCN_SH3 
precipitated nonphosphorylated, but not PKA-phosphory-
lated VASP (  Fig. 5 A  ). Consistently, PKA activity abolished 
The interaction of VASP with Abl SH3 domain has been previ-
ously confirmed (  Howe et al., 2002  ). We cloned the SH3 do-
mains of VAV1 ( Fig. 3 C ), and in pull-down experiments, VASP 
exclusively bound to SPCN_SH3, but not to VAV1 SH3 do-
mains or GST alone (  Fig. 3 D  ). Together, our data demonstrate 
a specifi  c and direct interaction of VASP with the SH3 domain 
of SPCN. 
  The SPCN SH3 domain binds to the triple 
GP  5   motif of VASP 
  To map the SPCN_SH3 binding site in VASP, two C-terminally 
truncated VSV-tagged VASP mutants were generated. VSV-
EVH1-PRR lacks the EVH2 domain. VSV-EVH1 lacks the central 
  Figure 3.       The SPCN SH3 domain speciﬁ  cally and directly interacts with 
VASP.   (A) Immobilized GST-SPCN_SH3 protein or GST alone was in-
cubated with conﬂ  uent EA.hy926 (left) or ECV304 (right) cell lysates. Pulled 
down proteins were probed by Western blotting with anti-VASP antibodies. 
For control, cell lysates (Lysate) were applied. (B) Lysates from EC-VASP 
+/+   
and EC-VASP 
  –  /  –   , were precipitated with SPCN_SH3 and probed as in A. 
(C) Coomassie-stained gel of puriﬁ  ed SH3 domains of SPCN and VAV1 
fused to GST or GST alone. (D) Immobilized GST-SH3 domains of SPCN 
and VAV1 or GST alone were incubated with puriﬁ  ed recombinant His  6  -
VASP. Precipitated protein was probed with His  6   antibodies in Western 
blots. His  6  -VASP was applied as positive control (Input).     209 FORMATION OF CORTICAL ACTIN CYTOSKELETONS   •   BENZ ET AL.
  Phosphomimetic substitution of S157 
blocks SPCN  –  VASP interaction 
  To address the contribution of the two VASP phosphorylation 
sites, S239 and T278, for SPCN  –  VASP complex formation, we 
generated VASP pseudophosphorylation mutants. Phosphory-
l  ation sites were either exchanged to acidic amino acids or to 
  alanines (mimicking a constitutively phosphorylated or unphos-
phorylated residue, respectively).  Fig. 5 C  gives a schematic re p-
re  sentation of the fi  ve mutants (VASP-DDE, -AAA, -DAA, -ADA, 
SPCN_SH3 binding to mutant VASP-SAA (S239 and T278 sites 
are not phosphorylatable) in our pull-down assay (unpublished 
data). To investigate whether PKA-mediated VASP phosphory-
l ation  regulates SPCN  –  VASP interaction in cells, we treated His  6 -
VASP – overexpressing 293 EBNA cells with Rp-8-Br-cAMPs 
(PKA antagonist) or with forskolin (PKA activator). Cell lysates 
were precipitated with SPCN_SH3 and probed with anti-His  6   anti-
bodies. SPCN_SH3 specifi  cally pulled down nonphos phorylated 
VASP, but not the S157-phosphorylated protein (  Fig. 5 B  ). 
  Figure 4.       The SPCN SH3 domain binds to the triple GP  5   motif of VASP.   (A) Schematic representation of VSV-tagged VASP and VASP mutants VSV-EVH1-PRR 
and VSV-EVH1. The PKA phosphorylation site S157 is printed in bold and highlighted in C. (B) Lysed VSV-VASP  –  , VSV-EVH1-PRR  –  , or VSV-EVH1  –  over-
expressing cells were pulled down with SPCN_SH3. Precipitated material and lysates were probed with anti-VSV antibodies in Western blotting. (C) 15-mer 
peptides, which span the VASP PRR, were synthesized in a 10   ×   10 peptide spot array (lines A  –  J and rows 1  –  10). VASP peptides were probed with 
GST-SPCN_SH3, followed by GST-speciﬁ  c antibodies, and bound antibody was detected with a secondary peroxidase-conjugated antibody. Peptides that 
bound to SPCN_SH3 (dark spots) are shown in bold. (D) Peptide F8 (P171-P185) or alanine mutants of this peptide were probed with SPCN_SH3. Alanine-
substitution of P177-P179 eliminates SPCN_SH3 binding. Film exposure times are given above each lane. (E) Immobilized SPCN_SH3 was incubated with 
His  6  -VASP (WT) or His  6  -VASP mutants P177A, P178A, and P179A. Pulled down material was analyzed with His  6  -speciﬁ  c antibodies. (F) EC-VASP 
  –  /  –    were 
transfected with His  6  -VASP (WT), empty expression vector (MOCK), or His  6  -VASP mutants P177A, P178A, and P179A. Cell lysates were immunoprecipi-
tated (IP) with     His  6   antibodies and precipitated material was blotted for SPCN (bottom). Cell lysates were run on the same gel and blotted for SPCN (top). 
Equal expression of VASP constructs is shown in   Fig. 10 D  .     JCB • VOLUME 180 • NUMBER 1 • 2008  210
and -AAE). In pull-down experiments, SPCN_SH3 interacted 
with recombinant VASP-AAA, -ADA, and -AAE, but not with 
VASP-DDE or -DAA, demonstrating that a negative charge 
at position 157 abolishes SPCN – VASP binding, whereas pseudo-
phosphorylations at positions 239 and 278 did not affect 
SPCN  –  VASP complex formation (  Fig. 5 D  ). To confi  rm the role 
of negative charges at position 157 for SPCN  –  VASP binding 
in cells, we reconstituted EC-VASP 
 – / –    with  wild-type  VASP, 
VASP-DAA, or -AAA. SPCN bound to VASP-AAA, but not to 
-DAA, in coimmunoprecipitation experiments, supporting a 
negative-regulation of SPCN  –  VASP binding by S157 phosphory-
lation (  Fig. 5 E  ). 
  SPCN colocalizes with S157 VASP, 
but not with phospho-S157 VASP, in 
contacting ECs 
  To investigate cellular functions of PKA-mediated S157 phos-
phorylation for SPCN  –  VASP complex formation, we analyzed 
the subcellular distribution of total-VASP, pS157-VASP, and 
SPCN in ECs. Because pS157-VASP levels are dynamically 
regulated during actin-based processes (  Howe et al., 2002  ), we 
investigated subcellular localizations of the proteins dependent 
on cell density. We investigated sparse cells (which have few 
contact sites;   Fig. 6 A  ), contacting cells (where about half of the 
cells have cell  –  cell junctions;   Fig. 6 B  ), and confl  uent cells 
(which have maximal contact sites;   Fig. 6 C  ). In sparse cells, 
total-VASP and pS157-VASP were predominantly found at fo-
cal adhesions and in more punctuate patterns at developing con-
tacts. Both antigens colocalized almost completely at these sites 
(  Fig. 6 A, a, b, and d  ). In contrast, SPCN was enriched at the cell 
periphery and did not colocalize with total-VASP or with pS157-
VASP (  Fig. 6 A, c, e, and f  ). In contacting cells, subcellular VASP 
distribution was strikingly different. A portion of total-VASP 
was still localized at focal adhesions, but a second VASP pool 
at cell  –  cell contacts appeared (  Fig. 6 B, a  ). The membrane-
associated VASP fraction colocalized with SPCN and was not 
S157 phosphorylated (  Fig. 6 B, a  –  e  ). In contacting cells, S157 
phosphorylation was lower compared with sparse cells. pS157-
VASP was mainly found at focal adhesions, and colocalization 
with SPCN was minor (  Fig. 6 B, b, c, and f  ). In confl  uent cells, 
total-VASP colocalized with SPCN at cell  –  cell junctions (  Fig. 6 C, 
a, c, and e  ), and pS157-VASP was almost undetectable (  Fig. 6 C, 
b, d, and f  ; note that anti – pS157-VASP  antibodies unspecifi  -
cally stain cell nuclei). To confi  rm that VASP phosphor ylation 
disappears with formation of cell  –  cell contacts, we quantifi  ed 
VASP phosphorylation by Western blotting using phosphory-
lation status-specifi  c antibodies directed to the sites S157, S239, 
and T278, respectively (  Fig. 7, A and B  ). ECV304 cells were 
detached, and equal cell numbers were seeded and allowed 
to grow for various times before lysis. 3 h after seeding, cells 
were sparse, lamellipodia were visible, and cell  –  cell contacts 
were virtually absent. Within 24 h, about half of the cells 
developed cell  –  cell contacts, and after 48 h cells were confl  uent 
(  Fig. 7 C  ). Consistent with high pS157 levels in detached cells 
(  Howe et al., 2002  ), VASP S157 phosphorylation was high in 
freshly seeded cells. S157 phosphorylation level decreased 
time-dependently when cells established cell  –  cell contacts. 
  Figure 5.       PKA-mediated phosphorylation of VASP at S157 inhibits 
its interaction with SPCN.   (A) Puriﬁ   ed His  6  -tagged VASP was S157-
phosphorylated (pS157-VASP) in vitro by PKA (+PKA) or left untreated 
(  –  PKA) and pulled down with immobilized SPCN_SH3. Precipitates 
were analyzed by Western blotting with His  6  -speciﬁ  c antibodies. (B) His  6  -
tagged VASP was overexpressed in 293 EBNA cells and cells were 
either treated with a PKA inhibitor (Rp-8-Br-cAMPs,   –  PKA) or a PKA 
stimulator (forskolin, +PKA). Cells were lysed, incubated with immobi-
lized SPCN_SH3, and complexes were analyzed with anti-His  6   anti-
bodies (Pull-down). (C) Schematic representation of His  6  -tagged VASP 
and mutants VASP-DDE, -AAA, -DAA, -ADA, and -AAE. In the mutants, 
phosphorylation sites S157, S239, and T278 were substituted by ala-
nines (A, open boxes) or negatively charged acidic amino acids (D or E, 
ﬁ  lled boxes). (D) Puriﬁ  ed His  6  -tagged VASP-DDE, -AAA, -DAA, -ADA, 
and -AAE (left) was pulled down with immobilized SPCN_SH3 and pre-
cipitated proteins were analyzed with His  6  -speciﬁ  c antibodies (right). 
Phosphorylation and phosphomimetic substitution of S157 induces a 
shift of VASP motility in SDS-PAGE. (E) EC-VASP 
  –  /  –     were transfected with 
His  6  -VASP (WT) or His  6  -tagged VASP-AAA or -DAA. Cell lysates were 
immunoprecipitated with     His  6   antibodies and precipitated material 
was blotted for SPCN. Equal expression of VASP constructs is shown 
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contacts in ECV304 cells as analyzed by phase-contrast micros-
copy. We tested whether SPCN – VASP complex formation  depends 
on PKA activity and cell confluency using coimmunopreci  p-
itation. VASP precipitated SPCN from confluent cells, but 
SPCN  –  VASP complexes were virtually absent in sparse and PKA-
activated confl  uent cells (  Fig. 7 D  ). 
Only trace amounts of pS157-VASP were detected in confl  uent 
cells. In contrast, phosphorylation levels of S239 and T278 were 
not dependent on confl  uency state. As control for intact PKA 
signaling, we stimulated confl  uent cells with 10    M  forskolin, 
which largely increased S157 phosphorylation (Fig. 7, A and B). 
Forskolin treatment had no visible effect on the morphology of 
  Figure 6.       SPCN colocalizes with S157-VASP, but not 
with phospho-S157-VASP in contacting ECs.   Confocal 
immunoﬂ   uorescence images of sparse (A), contacting 
(B), or conﬂ  uent (C) ECV304 cell stained for total-VASP 
(a, green), pS157-VASP (b, blue), and SPCN (c, red). 
(A) In sparse cells, total-VASP and pS157-VASP were found 
at focal adhesions (d, arrows). SPCN was enriched at 
the cell periphery and did not colocalize with total-VASP 
or pS157-VASP (e and f, arrowheads). (B) In contacting 
cells, total-VASP was found at focal adhesions, where it 
colocalized with pS157-VASP, and at cell  –  cell contacts, 
where it colocalized with SPCN (d and e, compare ar-
rows and arrowheads). pS157-VASP was mainly seen 
at focal adhesions and did not colocalize with SPCN 
(f, arrowheads). (C) In conﬂ  uent cells, pS157-VASP was 
almost not detectable (b; note: anti  –  pS157-VASP antibodies 
unspeciﬁ  cally stain cell nuclei). Total VASP was predomi-
nantly localized at cell  –  cell contacts, where it colocalized 
with SPCN (e, arrows). Arrows indicate sites with colocal-
ization; arrowheads indicate sites without colocalization. 
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and G and J  ). In Cl-VSV-SH3  –  expressing cells, VASP was en-
riched at the plasma membrane (  Fig. 8, B and E  ), and overlap of 
the proteins in this compartment was   >  80% (  Fig. 8, C and F  ). 
In contrast, colocalization of Cl-VSV and VASP was minor ( < 35%; 
  Fig. 8, I and L  ). Comparison of VASP localization in Cl-VSV-
SH3  –   and Cl-VSV  –  overexpressing cells suggested that the 
SPCN SH3 domain is suffi  cient to initiate VASP translocation 
( Fig. 8, B and E vs. H and K ). In Cl-VSV-SH3 – transfected cells, 
VASP was gone from stress fi  bers, recruited to cell  –  cell junc-
tions, and colocalized with SPCN_SH3. Pull-down and co-
precipitation experiments have demonstrated direct and specifi  c 
binding of VASP to the SPCN SH3 domain. If the claudin-fused 
SH3 domain exerts effects similar to those of full-size SPCN, 
we would predict that the individual domain competes with 
SPCN  –  VASP complex formation. To test this hypothesis, we 
  Ectopic expression of SPCN_SH3 recruits 
VASP and promotes cortical actin 
formation 
  To analyze the function of the SPCN  –  VASP interaction for 
cell  –  cell contact formation, we ectopically expressed SPCN 
SH3 domain at endothelial junctions and investigated VASP 
distribution and cortical cytoskeleton formation. SPCN_SH3 
was cloned to the C terminus of claudin-5 (Cl), which is an in-
tegral membrane protein of tight junctions ( Tsukita et al., 2001 ), 
and a VSV-tag was inserted in between (Cl-VSV-SH3). We used 
a VSV-tagged Cl construct lacking SH3 as control (Cl-VSV). 
Expression of the constructs in ECV304 cells was confi  rmed by 
Western blotting with VSV-specific antibodies (  Fig. 10 A  , 
inset). Anti-VSV antibodies detected Cl-VSV-SH3 and Cl-VSV 
almost exclusively at the plasma membrane (  Fig. 8, A and D 
  Figure 7.       VASP S157 phosphorylation de-
creases with the formation of cell  –  cell contacts.   
Conﬂ  uent ECV304 cells were detached, and 
a constant number of cells (7.5   ×   10 
4   cells/
cm 
2  ) was replated and grown for the indicated 
times before cells were analyzed for VASP 
phosphorylation (A and B), imaged by phase-
contrast microscopy (C), or immunoprecipitated 
with     VASP antibodies (D). (A) Western blots 
with anti-VASP or phosphorylation-speciﬁ  c anti-
bodies against pS157-, pS239-, and pT278-
VASP, respectively. As control for maximal PKA 
stimulation, cells were either detached and 
incubated in suspension for 15 min (Sp) or 
treated with 10     M forskolin (FSK) 72 h after 
replating. Open triangles represent S157-phos-
phorylated VASP (50 kD), and ﬁ  lled triangles 
indicate S157 nonphosphorylated VASP form 
(46 kD). (B) Kinetics of VASP S157 phosphory-
lation levels (open triangles) dependent on 
density of ECV304 cells (ﬁ  lled squares). Mag-
nitude of pS157-VASP (relative to the amount of 
total-VASP) was quantiﬁ   ed from Western blots 
(in A) by densitometric scans. pS157-VASP 
level of suspended (Sp) or FSK-treated cells 
are indicated. (C) Phase-contrast images of 
ECV304 cells. 3 and 6 h after seeding, cells 
were sparse and lamellipodia were visible 
(arrowheads). 12 h after replating, cells were 
maximally spread. Approximately half of the cells 
remained in this state 24 h after seeding (closed 
arrows), whereas the other half formed cell  –  cell 
contacts (open arrows). After 48 and 72 h, a 
conﬂ  uent  EC  monolayer formed. Bars, 30     m. 
(D) Lysates of conﬂ  uent, sparse, or FSK-treated 
conﬂ   uent ECV304 cells were immunoprecipi-
tated with     VASP antibodies. Lysates were 
analyzed by Western blotting with     SPCN 
or     VASP antibodies (left), and precipitated 
material was probed with     SPCN antibodies 
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 fl uorescence signal intensity, cortical actin fi  ber deposition was 
increased by more than twofold in Cl-VSV-SH3  –   over Cl-VSV  –
 expressing  cells. 
  Importance of SPCN  –  VASP complexes for 
endothelial barrier function 
  We investigated the function of SPCN  –  VASP interaction for 
permeability control in the endothelium. Stability of IEJs was 
analyzed in confluent cells with the calcium-switch model. 
Under basal conditions, cell  –  cell contacts are closed (  Mehta and 
Malik, 2006  ). Complexation of extracellular calcium ions abro-
gates cell  –  cell adhesion forces and initiates transition of cortical 
actin rings to stress fi  bers that culminates in disruption of cell  –
 cell contacts and gap formation in the monolayer (Fig. S1, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200709181/DC1). 
Opening of IEJs is followed by transition of macromolecular 
precipitated VASP from Cl-VSV  –   and Cl-VSV-SH3  –  transfected 
ECV304 cells and probed for SPCN. VASP precipitated less 
SPCN from Cl-VSV-SH3  –  expressing compared with Cl-VSV  –
  expressing cells (  Fig. 8 M  ). 
  What is the consequence of SPCN  –  VASP complex forma-
tion for perijunctional actin fi  lament assembly? Cl-VSV-SH3 
expression promoted cortical F-actin assembly, which was visu-
alized with fl  uorescent phalloidine (  Fig. 9, B and E  ). The for-
mation of actin fi  bers was prominent at Cl-VSV-SH3  –  positive 
membrane sections (  Fig. 9, A, C, D, and F  ; arrows and arrow-
heads indicate Cl-VSV-SH3  –  positive or   –  negative areas, re-
spectively), and signals overlapped by   >  95% at these sites. 
In contrast, although Cl-VSV localized to the plasma membrane 
(  Fig. 9, G and J  ), overexpression did not initiate cortical actin 
cytoskeleton formation (  Fig. 9, H and K  ). Colocalization of 
Cl-VSV and actin was low (  <  40%; I and L). As judged from 
  Figure 8.       Ectopic expression of SPCN_SH3 recruits VASP to the plasma membrane.   ECV304 cells were transfected with the SPCN SH3 domain fused to 
VSV-tagged claudin-5 (Cl-VSV-SH3) or with VSV-tagged claudin-5 alone (Cl-VSV, control), ﬁ  xed, and processed for confocal immunoﬂ  uorescence micros-
copy. Cells were stained for Cl-VSV-SH3 (A and D; green), Cl-VSV (G and J; green), and VASP (B, E, H, and K; red). Images D  –  F and J  –  L show magniﬁ  ed 
views of the indicated areas in the preceding images. Arrows in the overlays C, F, I, and L indicate sites with colocalization; arrowheads indicate sites 
without colocalization. Bars, 15     m. (M) Lysates of Cl-VSV  –   and Cl-VSV-SH3  –  transfected ECV304 cells were immunoprecipitated (IP) with     VASP anti-
bodies. Lysates were analyzed by Western blotting with anti-SPCN, -VASP, and -VSV antibodies (left), and precipitated material was analyzed with anti-SPCN 
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bradykinin (  Renne et al., 2005  ). Tracer measurements revealed 
that bradykinin-induced vascular leakage was significantly 
increased in VASP 
 – / –    over wild-type mice (4.9- vs. 3.2-fold of 
saline;   n   = 7; P   <   0.05;   Fig. 10 C  ). To specifi  cally address the 
impact of PKA-regulated SPCN  –  VASP interaction for inter-
endothelial adhesion and permeability, we used a rescue strategy. 
EC-VASP 
 – / –    cells were reconstituted with SPCN binding-
defective VASP mutants P178A, P177A, P179A, (  Fig. 4, 
E and F  ) or wild-type protein and subjected to a calcium switch. 
Consistent with nontransfected cells, FITC-albumin leakage 
was signifi  cantly higher in mock-transfected EC-VASP 
 – / –    over 
EC-VASP 
+/+   cells (0.67 vs. 0.31 for 3 h;   n   = 6; P   <   0.05; 
  Fig. 10, D and E  ). Expression of wild-type VASP in EC-VASP 
 – / –   
cells reduced leakage (0.51 vs. 0.67 of mock for 3 h;   n   = 6; P   <   
0.05; transfection rates were 23  –  28% as determined by FACS 
analyses). Reconstitution of EC-VASP 
 – / –    cells with SPCN 
binding-defective mutants P177A, P178A, and P179A had minor 
effects on permeability (0.59, 0.63, 0.58 vs. 0.51 of wild-type 
VASP, 3 h,   n   = 6, P   <   0.05;   Fig. 10 D  ). Finally, we tested the rel-
evance of VASP S157 phosphorylation for SPCN  –  VASP-mediated 
tracers (  Citi, 1992  ). ECV304 cells were seeded on porous fi  lters 
and transfected with Cl-VSV-SH3 or Cl-VSV (transfection 
rates 30  –  37%) before FITC-albumin addition to apical cham-
bers. Western blot analyses revealed equal expression levels of 
the constructs (  Fig. 10 A  , inset). Basal permeability of mono-
layers was recorded for 2 h. After removal of extracellular cal-
cium (4 mM EGTA;   Citi, 1992  ), transition of fl  uorescent tracer 
into the lower chambers was determined for an additional 3.5 h. 
FITC-albumin leakage through Cl-VSV-SH3  –  overexpressing 
cell monolayers was signifi  cantly lower as compared with Cl-
VSV  –  transfected cells (0.15 vs. 0.11 for 3.5 h;   n   = 7; P   <   0.05; 
  Fig. 10 A  ). We analyzed the function of SPCN  –  VASP com-
plexes for paracellular permeability in EC-VASP 
+/+   and  EC-
VASP 
 – / –    cells (  Fig. 10 B  , inset). In the calcium-switch assay, 
permeability of EC-VASP 
 – / –    exceeded EC-VASP 
+/+   monolayers 
(0.39 vs. 0.18 for 2 h;   n   = 7; P   <   0.05;   Fig. 10 B  ), suggesting 
that VASP defi  ciency interferes with the stability of IEJs. To test 
this hypothesis in whole animals, we analyzed VASP-null 
mice in a skin vascular leakage model. Edema formation was 
induced by subdermal application of the infl  ammatory mediator 
  Figure 9.       Ectopic expression of SPCN_SH3 promotes 
cortical actin formation.   ECV304 cells were transfected 
with Cl-VSV-SH3 or Cl-VSV (control), and analyzed by 
confocal immunoﬂ   uorescence microscopy. Cells were 
stained for Cl-VSV-SH3 (A and D), Cl-VSV (G and J), and 
actin (B, E, H, and K). Images D  –  F and J  –  L are magni-
ﬁ  ed views of the indicated areas in the preceding images. 
Arrows in the overlays (C, F, I, and L) indicate sites with 
colocalization; arrowheads indicate sites without colocal-
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  Discussion 
 The endothelial lining of the vessel wall acts as a permeable fi  lter, 
which allows selective transition of water, solutes,  macromolecules, 
and cells from the luminal to the abluminal side of the barrier. 
Paracellular permeability is regulated by a complex interplay of 
cellular adhesive and counteradhesive forces, which are generated 
by transmembrane adhesion molecules, actin fi  lament assembly, 
and actinomyosin molecular motors. This study links the spectrin-
based skeleton to remodeling of the actin fi  lament network. 
barrier function.   Reconstitution of EC-VASP 
 – / –    cells  with VASP-
AAA rescued leakage similarly to wild-type protein (0.50 and 
0.51 at 3 h,   n   = 6, P   <   0.05;   Fig. 10 E  ). In contrast, expression 
of the SPCN binding-defective mutant VASP-DAA that mimics 
S157 phosphorylated VASP, failed to rescue barrier function 
(0.60 vs. 0.67 of mock-transfected cells for 3 h;   n   = 6; P = n.s.; 
  Fig. 10 E  ). Together, the data indicate that SPCN  –  VASP com-
plexes stabilize EC  –  cell contacts with implication for vascular 
barrier integrity, and that VASP S157 phosphorylation regulates 
this process. 
  Figure 10.       Importance of SPCN  –  VASP complexes for endothelial barrier function.   Permeability of Cl-VSV  –   (orange) or Cl-VSV-SH3  –  overexpressing (green) 
conﬂ  uent ECV304 cells (A), or EC-VASP 
  –  /  –    (magenta) or EC-VASP 
+/+   (blue; B) were analyzed in the calcium-switch model. Absorbance at 492 nm in the lower 
compartments determined transition of FITC-albumin tracer through the monolayers. Arrows indicate EGTA application. Means and SE are given.   n   = 7. *, P   <   
0.05. (insets) Western blots of lysed Cl-VSV  –   or Cl-VSV-SH3  –  transfected ECV304 cells, probed with anti-VSV tag antibodies (A) or EC-VASP 
+/+   or EC-VASP 
  –  /  –    cells 
analyzed with anti-VASP antibodies. GAPDH served as loading control (B). (C) Comparison of bradykinin-induced vascular leakage in VASP 
  –  /  –    and wild-type 
mice skin. In Evans blue  –  injected mice, edema formation was induced by subdermal application of 100     M bradykinin or saline. Evans blue extravasation was 
quantiﬁ  ed photometrically. Values are blotted relative to saline injection.   n   = 7. *, P   <   0.05. (D and E) Permeability of EC-VASP 
  –  /  –   , transfected with His  6  -VASP (WT, 
orange) and (D) His  6  -VASP mutants P177A (light green), P178A (black), and P179A (magenta) or (E) His  6  -tagged VASP-AAA (green) or -DAA (brown) was ana-
lyzed in the calcium-switch model. Permeability of mock-transfected EC-VASP 
  –  /  –    and EC-VASP 
+/+   are given in red and blue, respectively. Mean   ±   the SEM.   n   = 6. 
*, P   <   0.05. (insets) Western blot of lysed EC-VASP 
  –  /  –    transfected with indicated VASP constructs and probed with anti-His  6   antibodies. GAPDH is loading control.     JCB • VOLUME 180 • NUMBER 1 • 2008  216
blotting and immuno  fl  uorescence microscopy (Fig. S2, available 
at http://www.jcb.org/cgi/content/full/jcb.200709181/DC1), 
excluding a modulatory role of EVL on SPCN  –  VASP complex 
formation in our system. In yeast nucleus, VASP did not to bind 
to the bait SPCN_SH3 (  Bournier et al., 2006  ). Because active 
PKA accounts for high kinase activity in yeast nuclei (  Griffi  oen 
and Thevelein, 2002  ), PKA could phosphorylate VASP at S157 
and inhibit SPCN_SH3  –  VASP interaction. Within the VASP 
PRR, peptide scans identifi  ed sequences comprising the triple 
GP  5   (F2, F8;   Fig. 4 C  ) as important for SPCN_SH3 binding. It is 
not clear whether both peptides contribute equally to SPCN  –
  VASP complex formation or whether one harbors the preferred 
SH3 binding site of full-length VASP. Possibly, the two peptides 
together form a surface for SPCN_SH3 docking. Cooperative 
binding is known for other proline recognition domains (  Li, 2005  ). 
SH3 domains interact with proline-rich ligands with consensus 
sequences + x   Px  P  or    Px   Px + (class I or class II ligands, 
where x is any,      is a hydrophobic, and + is a positively charged 
amino acid, respectively;   Kay et al., 2000  ). Because peptides F2 
and F8 do not contain positively charged amino acid residues, 
SPCN_SH3 appears to belong to the atypical SH3 domains. 
These domains prefer ligands in which hydrophobic residues 
contact the specifi  city pocket (  Mayer, 2001  ). Consistently, SPCN 
SH3 domain was shown to interact with the peptide PPLAL-
TAPPPA at the C terminus of rat amiloride-sensitive epithelial 
Na 
+   channel      subunit  (   rENaC), which lacks a positively 
charged amino acid (  Rotin et al., 1994  ). Furthermore, the Abl 
SH3 domain, which binds to VASP (  Howe et al., 2002  ), is also an 
atypical SH3 domain (  Mayer, 2001  ). SPCN_SH3 binds to the 
Ena/VASP protein family member EVL, but the binding site was 
not mapped (  Rotter et al., 2005  ). EVL lacks a triple GP  5   motif 
that mediates VASP binding to SPCN (  Fig. 4  ). The other family 
member Mena does not bind to SPCN_SH3 ( Bournier et al., 2006 ). 
Pull-downs, coprecipitations, and peptide scan data roughly sug-
gest a 1:1 stoichiometry of VASP and spectrin in the complex. 
Because VASP and spectrin are tetrameric in cells, the exact bind-
ing mechanism remains speculative. EVL binding to Abl and 
nSrc SH3 domains, but not to profi  lin is abolished by PKA-
mediated phosphorylation of the S157 equivalent site (  Lambrechts 
et al., 2000  ). Consistently, when regulated by PKA activity, 
SPCN_SH3 binds to the VASP triple GP  5   motif (  Figs. 4 and 5  ). 
Profi  lin binding to VASP was thought to be mediated by the triple 
GP  5   motif (  Kang et al., 1997  ); however, recent structural analyses 
challenged this hypothesis ( Ferron et al., 2007 ). We tested whether 
profi  lin competes with SPCN SH3 domain for VASP binding. 
In competition experiments, profi  lin did not interfere with SPCN  –
  VASP complex formation (Fig. S3, available at http://www.jcb
.org/cgi/content/full/jcb.200709181/DC1), supporting the notion 
of   Ferron et al.   (  2007  ) that high-affi  nity profi  lin/VASP binding is 
mediated by a more C-terminal site, which is different from the 
triple GP  5   motif. 
  Regulation and functional importance of 
SPCN  –  VASP complexes 
  Our study provides evidence that VASP regulates actin forma-
tion in defi  ned subcellular compartments. Targeting of VASP to 
these sites is regulated by PKA activity. In sparse ECs, VASP is 
  SPCN  –  VASP assemble perijunctional 
multiprotein complexes 
  VASP was originally identifi  ed in platelets, and VASP activity 
participates in a variety of actin-based processes, such as adhe-
sion or spreading in these cells. Subsequently, the importance of 
VASP-driven actin assembly was established in other cell lines, 
including keratinocytes (  Vasioukhin et al., 2000  ), leukocytes 
(  Lawrence and Pryzwansky, 2001  ), fi  broblasts (  Bear et al., 
2002  ), smooth muscle (  Chen et al., 2004  ), epithelial cells 
(  Lawrence et al., 2002  ), and ECs (  Price and Brindle, 2000  ), in 
vessels of animal models and in humans (  Munzel et al., 2003  ). 
In epithelial and keratinocyte monolayers, proteins of the Ena/
VASP family participate in cell  –  cell adhesion and formation 
of adhesion zippers by a mechanism that requires    -catenin 
(  Vasioukhin et al., 2000  ) and cadherin (  Scott et al., 2006  ). Ena/
VASP proteins promote actin polymerization and assembly and 
several models of VASP-mediated F-actin control have been 
proposed, including regulation of nucleation, bundling, branching, 
and capping (  Barzik et al., 2005  ;   Schirenbeck et al., 2006  ). It is 
the interaction with SPCN that may give the spacing for VASP-
driven plasma membrane  –  associated actin fi  lament assembly. 
Bound to SPCN, VASP assembles multiprotein complexes with 
IEJ components. VASP and the tight junction protein ZO-1 co-
immunoprecipitate from lysates of ECs (  Comerford et al., 2002  ). 
However, the interaction appears to be indirect (  Lawrence et al., 
2002  ). SPCN interactions with VASP (  Figs. 1  –  3  ) and with ZO-1 
(  Tsukamoto and Nigam, 1997  ) could bridge the molecules. 
    -Catenin appears to be another component of SPCN  –  VASP 
multi protein complexes. In   -catenin – defi  cient keratinocytes, 
VASP localization to cell  –  cell borders is impaired, suggesting that 
   -catenin  interacts with VASP at sites of intercellular adhe-
sion (  Vasioukhin et al., 2000  ). Evidence for a direct interaction 
of    -catenin  and  VASP is missing, and adaptors might link the 
proteins. Because     -catenin directly binds to spectrins (  Pradhan 
et al., 2001  ), which in turn interact with VASP (  Fig. 2  ), lack of 
   -catenin – SPCN  interaction in    -catenin – null  cells  might  ac-
count for defective recruitment of VASP to cell  –  cell contacts. 
Consistently, spectrin tetramer assembly at the plasma mem-
brane has been shown to be diminished in cells expressing an 
    -catenin mutant that fails to associate with the plasma mem-
brane (  Pradhan et al., 2001  ). In summary, the data argue for 
large complexes of junctional proteins, spectrin, and VASP, and 
possibly other unidentifi  ed proteins, at cell  –  cell contacts. 
  SPCN SH3 domain mediates interaction 
with VASP 
 One of the key fi  ndings of this study is that the spectrin SH3 domain, 
which is unique to     -spectrins and not found in other isoforms, 
specifi  cally interacts with VASP. PKA-mediated phosphorylation 
controls SPCN_SH3  –  VASP interaction (  Fig. 5  ). Consistently, 
binding of VASP and the Ena/VASP protein family member EVL 
to SH3 domains of Abl and Src is dependent on PKA activity 
(  Ahern-Djamali et al., 1999  ;   Lambrechts et al., 2000  ;   Howe et al., 
2002  ). Yeast two-hybrid screens indicated EVL interaction with 
SPCN (  Rotter et al., 2005  ), supporting the coupling of spectrin-
based membrane skeletons with proteins involved in actin dynamics. 
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sample cup method. After isoelectric focusing by a standard multistep gra-
dient, strips were equilibrated in buffer E (6 M urea, 2% SDS, 30% glycer-
ine, 50 mM Tris-HCl, 30 mM DTT, and 280 mM iodoacetamide, pH 8.8) 
and transferred onto 10% Tris-Glycine SDS gels for second dimension pro-
tein separation. 2D gels were stained with colloidal Coomassie (G-250), 
as previously described (  Neuhoff et al., 1988  ), and gel images were pro-
cessed using the Proteomweaver software version 2.2 (Deﬁ  niens). Differen-
tially detected spots were excised manually. In some experiments, the 
SPCN spot migrated as a doublet, probably caused by limited separation 
capacity of high molecular proteins in the gel system. Gel plugs were 
washed, equilibrated, and treated with trypsin, as previously described 
(  Shevchenko et al., 1996  ). Generated peptides were extracted with 0.1% 
triﬂ  uoroacetic acid solution. An aliquot was spotted onto a MALDI-steel 
target (Bruker Daltonik) together with saturated     -cyano-4-hydroxycinnamic 
acid solution. MALDI-PMF measurements were performed with an Ultraﬂ  ex 
MALDI-TOF/TOF mass spectrometer (Bruker Daltonik). Acquired spectra 
were processed using the mascot algorithm (V. 1.9) and the current National 
Center for Biotechnology Information protein database. 
  Immunoprecipitations and GST pull-down assays 
  For immunoprecipitation, conﬂ  uent EA.hy926 cells were lysed (50 mM Tris-
HCl, pH 8.0, 500 mM NaCl, 1% NP-40, and protease inhibitor cocktail 
[Roche]). Lysates were cleared by centrifugation, supernatants were adjusted 
to 50 mM Tris-HCl, 150 mM NaCl, and 0.3% NP-40, and immunopreci  p-
itated using VASP- and SPCN-speciﬁ  c antibodies or controls. To analyze 
SPCN-binding to His  6  -VASP mutants His  6  -VASP-P177A, -P178A, -P179A, 
-AAA, and -DAA, we transfected EC-VASP 
  –  /  –    with the constructs, lysed cells 
24  –  36 h later, and immunoprecipitated with     His  6   antibodies. To correlate 
SPCN  –  VASP interaction with cell density and VASP phosphorylation, equal 
numbers of conﬂ  uent, sparse, and okadaic acid/forskolin  –  treated (discussed 
later in this section) conﬂ  uent ECV304 cells were lysed and immunoprecipi-
tated with     VASP antibodies. To investigate interaction of Cl-VSV and Cl-VSV-
SH3 with VASP, ECV304 cells were transiently transfected with the two 
constructs, lysed 24 h later, and immunoprecipitated with     VASP antibodies. 
Expression of Cl-VSV did not alter the subcellular VASP distribution as 
compared with mock-transfected cells. For GST pull-down assays, ECs 
(EA.hy926, ECV304, EC-VASP 
+/+  , EC-VASP 
  –  /  –   , and HUVEC) or transfected 
293 EBNA cells were grown to conﬂ  uence and lysed in 40 mM Hepes-NaOH, 
pH 7.4, 150 mM NaCl, 1% NP-40, and protease inhibitors. Lysates were 
cleared by centrifugation and incubated with 5     g immobilized GST-fusion 
protein or GST alone. GST pull-down assays with puriﬁ  ed recombinant VASP 
were performed as above in this paragraph, using 1     g PKA-phosphory-
lated or unphosphorylated His  6  -VASP or 1     g of the following mutants: His  6  -
VASP-DDE, -AAA, -DAA, -ADA, -AAE, -P177A, -P178A, and -P179A. 
Precipitated material was analyzed with anti-His  6   antibodies. To analyze 
whether PKA activity regulates SPCN  –  VASP interaction in cells, His  6  -VASP 
was overexpressed in 293 EBNA cells. 20 h after transfection, cells were 
either treated with 1     M okadaic acid (Sigma-Aldrich) and 10     M forskolin 
(Sigma-Aldrich) or 10     M Rp-8-Br-cAMPs (Biolog) for 30 min before cell lysis 
and GST pull-down experiments. 
  Endothelial permeability assays 
  For calcium-switch experiments, ECV304 (or EC-VASP 
  –  /  –   ) cells were seeded 
at a density of 7.5   ×   10 
4   cells/cm 
2   onto PET ﬁ  lters (Becton Dickinson), and 
36 h later they were transfected with cDNAs coding for Cl-VSV or Cl-VSV-
SH3 (or His  6  -VASP-WT, -P177A, -P178A, -P179A, -AAA, -DAA, or mock). 
Transfection rates were determined by FACS analysis using cells that were 
transfected with a vector coding for enhanced green ﬂ  uorescent protein. 
15 h later, overexpressing cells were washed, incubated in phenol red-free 
DME (supplemented with 10% FBS and 1.8 mM calcium) and 4 mg/ml 
FITC-albumin (Sigma-Aldrich) was added to the upper chambers. Basal 
permeability was followed for 2 h, then extracellular Ca 
2+   was removed by 
addition of EGTA (4 mM in the apical and the basal chambers;   Citi, 1992  ). 
100-    l aliquots were collected from the lower compartments, and FITC-
albumin absorbance was measured at 492-nm wavelength (Tecan Spectra 
Rainbow). Calcium switch experiments with conﬂ  uent EC-VASP 
+/+   and 
EC-VASP 
  –  /  –    cells were done accordingly. 
  Skin vascular leakage assay 
  5  –  7-wk-old VASP 
  –  /  –     mice and their wild-type littermates were used. 
Mice were anesthetized with a single i.p. injection of ketamine/xylazine 
(80 mg/kg ketamine and 10 mg/kg xylazine), and a total of 200     l of sterile-
ﬁ  ltered 0.25% Evans blue dissolved in sterile saline (0.9% NaCl) was in-
jected i.v. in the retroorbital plexus. 10 min later, 50     l of bradykinin 
(100     M; Sigma-Aldrich) or saline was injected i.d. into the dorsal region 
by   using a tuberculin syringe. The animals were killed 10 min after the 
PKA-phosphorylated at S157 and not bound to SPCN at the 
plasma membrane (  Figs. 6 and 7  ). S157-phosphorylated protein 
is enriched at focal adhesions and could interact with vinculin, 
zyxin, and migfi  lin at these sites (  Drees et al. 2000  ;   Hoffman et al., 
2006  ). When ECs establish cell  –  cell junctions, pS157 levels de-
crease and SPCN  –  VASP complexes form (  Figs. 6 and 7  ). At the 
plasma membrane, VASP participates in the formation of a cor-
tical actin ring ( Mehta and Malik, 2006 ). The cortical actin cyto-
skeleton is pivotal for the integrity and stability of IEJs, which 
in turn is essential for EC barrier function (  Ermert et al., 1995  ). 
Consistently, vascular leakage is increased in VASP-defi  cient mice 
(  Fig. 10 C  ). The data support previous observations that indi-
cated a role of VASP for actin assembly at cell  –  cell contact sites 
in PKA-treated and hypoxia-activated ECs (  Comerford et al., 
2002  ;   Rosenberger et al., 2007  ). Consistent with the relevance 
of VASP for barrier function in stressed endothelium, VASP-
null mice do not suffer from constitutive (basal) swellings. Only 
in activated vessels is permeability increased (  Fig. 10 C  ). 
  In summary, we have identifi  ed a new mechanism for for-
mation of cortical actin cytoskeletons. SPCN  –  VASP complexes 
trigger perijunctional actin fi  lament assembly, and PKA-driven 
VASP phosphorylation at S157 inhibits this process. SPCN  –  VASP 
interactions improve cell  –  cell adhesion, with implications for 
endothelial barrier permeability. 
  Materials and methods 
  Animals 
  Generation of VASP-deﬁ  cient mice has been previously reported (  Hauser 
et al., 1999  ). Animals were backcrossed for more than eight generations to 
C57BL/6J background. All experiments and animal care were approved 
by the Regierung von Unterfranken. 
  Cell culture 
  EA.hy926 cells were cultivated as previously described (  Renne et al., 
2005  ). ECV304 and 293 EBNA cells were grown in DME containing 
4.5 g/liter glucose supplemented with 10% FBS. Wild-type and VASP-deﬁ  cient 
murine microvascular myocardial ECs (EC-VASP 
+/+   or EC-VASP 
  –  /  –   , respec-
tively) were generated, characterized, and cultured as previously described 
(  Golenhofen et al., 2002  ;   Schlegel et al., 2007  ). 293 EBNA, ECV304, 
EC-VASP 
+/+  , and EC-VASP 
  –  /  –    cells were transiently transfected with Lipo-
fectamine 2000 (Invitrogen) and analyzed 12  –  36 h later. To correlate 
VASP phosphorylation with cell density, ECV304 cells were detached with 
trypsin-EDTA and collected into medium containing 10% FBS. Cells were 
maintained in suspension (Sp) for 15 min before lysis or replated on tissue 
culture plates (7.5   ×   10 
4   cells/cm 
2  ). 3, 6, 12, 24, 48, or 72 h after seed-
ing, adherent cells were photographed, lysed in SDS-sample buffer, and 
analyzed by Western blotting (loading was normalized to equal cell 
counts) with VASP- and phospho-VASP  –  speciﬁ  c antibodies. As control for 
maximal PKA stimulation, ECV304 cells were treated for 10 min with 
10     M forskolin 72 h after replating. The relative amount of pS157-VASP 
to total-VASP was quantiﬁ  ed from M4 Western blots by densitometric scans 
(ImageJ version 1.34s; National Institutes of Health). 
  2D-PAGE proteome analysis of VASP-AAA  –   and VASP-DDE  –  binding 
proteins 
  Puriﬁ  ed recombinant His  6  -VASP-AAA or -DDE was covalently coupled to 
Afﬁ   -Gel 10 (Bio-Rad Laboratories). Cytosolic proteins from conﬂ   uent 
EA.hy926 cells in PBS were prepared as previously described (  Herwald et al., 
1996  ) and applied to His  6  -VASP-AAA or -DDE afﬁ  nity columns. Columns 
were washed with PBS, and bound proteins were eluted with glycine/HCl 
pH 5.0, pH 4.0, pH 3.0, and pH 2.0. pH 2.0 fractions were analyzed by 
2D-PAGE and mass spectrometry. Electrophoresis equipment was pur-
chased from GE Healthcare. For ﬁ  rst dimension protein separation, protein 
samples were dissolved in rehydration-buffer (7 M urea, 2 M thiourea, 2% 
CHAPS, and 2% IPG-buffer 3  –  10 NL) and applied to IPG strips using the JCB • VOLUME 180 • NUMBER 1 • 2008  218
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    Note added in proof.   While this paper was in ﬁ  nal review, an independent 
study using genetically altered mice demonstrated increased vascular leakage 
in Ena/VASP-deﬁ  cient animals (Furman, C., A.L. Sieminski, A.V. Kwiatkowski, 
D.A. Rubinson, E. Vasile, R.T. Bronson, R. F  ä  ssler, F.B. Gertler. 2007.   J. Cell Biol  . 
179:761  –  775). The study supports the critical role for Ena/VASP-driven actin 
assembly at endothelial cell  –  cell junctions in vivo, for which the spectrin  –  VASP 
interaction appears to be an important regulator.
    References 
   Ahern-Djamali ,   S.M. ,   C.    Bachmann ,   P.    Hua ,   S.K.    Reddy ,   A.S.    Kastenmeier , 
 U.    Walter ,  and   F.M.    Hoffmann .   1999 .   Identifi  cation of profi  lin and 
src homology 3 domains as binding partners for   Drosophila   enabled.  
  Proc. Natl. Acad. Sci. USA   .    96 : 4977  –  4982 .    
   Bachmann ,   C. ,   L.    Fischer ,   U.    Walter ,  and   M.    Reinhard .   1999 .   The  EVH2  domain  of 
the vasodilator-stimulated phosphoprotein mediates tetramerization, F-actin 
binding, and actin bundle formation.       J. Biol. Chem.     274 : 23549  –  23557 .   
   Ball ,   L.J. ,   R.    Kuhne ,   B.    Hoffmann ,  A.    Hafner ,   P.     Schmieder  ,   R.   Volkmer-Engert , 
 M.    Hof ,   M.    Wahl ,   J.    Schneider-Mergener ,   U.    Walter ,   et  al .   2000 .   Dual 
epitope recognition by the VASP EVH1 domain modulates polyproline 
ligand specifi  city and binding affi  nity.       EMBO J.     19 : 4903  –  4914 .    
   Barzik ,   M. ,   T.I.    Kotova ,   H.N.    Higgs ,   L.    Hazelwood ,   D.    Hanein ,   F.B.    Gertler , 
and   D.A.    Schafer .   2005  .   Ena/VASP proteins enhance actin polymer-
ization in the presence of barbed end capping proteins.       J. Biol. Chem.   
 280 : 28653  –  28662 .    
   Bear ,   J.E. ,   T.M.    Svitkina ,   M.    Krause ,   D.A.    Schafer ,   J.J.    Loureiro ,   G.A.    Strasser , 
 I.V.    Maly ,   O.Y.    Chaga ,   J.A.    Cooper ,   G.G.    Borisy ,  and   F.B.    Gertler .   2002 . 
  Antagonism between Ena/VASP proteins and actin fi  lament capping reg-
ulates fi  broblast motility.       Cell   .    109 : 509  –  521 .    
   Bennett ,  V. , and  A.J.   Baines .  2001 .  Spectrin and ankyrin-based pathways: metazoan 
inventions for integrating cells into tissues.       Physiol. Rev.     81 : 1353  –  1392 .  
   Blume ,   C. ,   P.M.    Benz ,   U.    Walter ,   J.    Ha ,   B.E.    Kemp ,  and   T.    Renne .   2007 .   AMP-
activated protein kinase impairs endothelial actin cytoskeleton assembly 
by phosphorylating vasodilator-stimulated phosphoprotein.       J. Biol. Chem.    
 282 : 4601  –  4612 .    
   Bournier ,  O. ,  Y.   Kroviarski ,  B.   Rotter ,  G.   Nicolas ,  M.C.   Lecomte , and  D.   Dhermy . 
  2006  .   Spectrin interacts with EVL (Enabled/vasodilator-stimulated phospho-
protein-like protein), a protein involved in actin polymerization.       Biol. 
Cell   .    98 : 279  –  293 .    
   Brannetti ,   B. ,   A.    Via ,   G.    Cestra ,   G.    Cesareni ,  and   M.    Helmer-Citterich .   2000 . 
  SH3-SPOT: an algorithm to predict preferred ligands to different mem-
bers of the SH3 gene family.       J. Mol. Biol.     298 : 313  –  328 .    
   Chen ,   L. ,   G.    Daum ,   K.    Chitaley ,   S.A.    Coats ,   D.F.    Bowen-Pope ,   M.    Eigenthaler , 
 N.R.    Thumati ,   U.    Walter , and   A.W.     Clowes  .   2004 .  Vasodilator-stimulated 
phosphoprotein regulates proliferation and growth inhibition by nitric 
oxide in vascular smooth muscle cells.       Arterioscler. Thromb. Vasc. Biol.   
 24 : 1403  –  1408 .    
      Citi  ,   S.     1992  .   Protein kinase inhibitors prevent junction dissociation induced by low 
extracellular calcium in MDCK epithelial cells.       J. Cell Biol.     117 : 169  –  178 .    219 FORMATION OF CORTICAL ACTIN CYTOSKELETONS   •   BENZ ET AL.
   Neuhoff ,   V. ,   N.    Arold ,   D.    Taube ,  and   W.    Ehrhardt .   1988 .   Improved  staining  of 
proteins in polyacrylamide gels including isoelectric focusing gels with 
clear background at nanogram sensitivity using Coomassie Brilliant Blue 
G-250 and R-250.       Electrophoresis   .    9 : 255  –  262 .    
   Pinder ,   J.C. ,  and   A.J.    Baines .   2000 .   A  protein  accumulator.     Nature   .    406 : 
253  –  254 .    
   Pradhan ,   D. ,   C.R.    Lombardo ,   S.    Roe ,   D.L.    Rimm ,  and   J.S.    Morrow .   2001 .  
alpha-Catenin binds directly to spectrin and facilitates spectrin-mem-
brane assembly in vivo.       J. Biol. Chem.     276 : 4175  –  4181 .    
   Price ,   C.J. ,  and   N.P.    Brindle .   2000 .   Vasodilator-stimulated  phosphoprotein  is 
involved in stress-fi  ber and membrane ruffl  e formation in endothelial 
cells.     Arterioscler. Thromb. Vasc. Biol.     20 : 2051  –  2056 .  
   Renne ,   T. ,   K.    Schuh ,  and   W.    Muller-Esterl .   2005 .   Local  bradykinin  formation  is 
controlled by glycosaminoglycans.       J. Immunol.     175 : 3377  –  3385 .  
   Rosenberger ,   P. ,   J.    Khoury ,   T.    Kong ,   T.    Weissmuller ,   A.M.    Robinson ,  and   S.P.  
 Colgan .   2007 .   Identifi   cation of vasodilator-stimulated phosphoprotein 
(VASP) as an HIF-regulated tissue permeability factor during hypoxia.   
  FASEB J.     21 : 2613  –  2621 .    
   Rotin ,  D. ,  D.   Bar-Sagi ,  H.   O ’ Brodovich ,  J.   Merilainen ,  V.P.   Lehto ,  C.M.   Canessa , 
 B.C.    Rossier , and   G.P.     Downey  .   1994  .   An SH3 binding region in the epi-
thelial Na+ channel (alpha rENaC) mediates its localization at the apical 
membrane.     EMBO J.     13 : 4440  –  4450 .  
   Rotter ,   B. ,   O.    Bournier ,   G.    Nicolas ,   D.    Dhermy ,  and   M.C.    Lecomte .   2005 . 
  AlphaII-spectrin interacts with Tes and EVL, two actin-binding proteins 
located at cell contacts.       Biochem. J.     388 : 631  –  638 .    
   Schirenbeck ,   A. ,   R.    Arasada ,   T.    Bretschneider ,   T.E.    Stradal ,   M.    Schleicher , and 
 J.    Faix .   2006 .   The  bundling  activity  of  vasodilator-stimulated  phospho-
protein is required for fi  lopodium formation.       Proc. Natl. Acad. Sci. USA   .  
 103 : 7694  –  7699 .    
   Schlegel ,   N. ,   S.    Burger ,   N.    Golenhofen ,   U.    Walter ,   D.    Drenckhahn ,  and   J.  
 Waschke .   2007  .   The role of VASP in the regulation of cAMP- and Rac 
1-mediated endothelial barrier stabilization.       Am. J. Physiol. Cell Physiol.   
 doi:10.1152/ajpcell.00273.2007.   
   Scott ,   J.A. ,   A.M.    Shewan ,   N.R.    den  Elzen ,   J.J.    Loureiro ,   F.B.    Gertler ,  and   A.S.  
  Yap  .   2006  .   Ena/VASP proteins can regulate distinct modes of actin orga-
nization at cadherin-adhesive contacts.       Mol. Biol. Cell   .    17 : 1085  –  1095 .    
   Sechi ,  A.S. ,  and   J.    Wehland .   2004 .   ENA/VASP  proteins:  multifunctional  regula-
tors of actin cytoskeleton dynamics.       Front. Biosci.     9 : 1294  –  1310 .    
   Shevchenko ,   A. ,   M.    Wilm ,   O.    Vorm ,  and   M.    Mann .   1996 .   Mass  spectrometric 
sequencing of proteins silver-stained polyacrylamide gels.       Anal. Chem.   
 68 : 850  –  858 .    
   Takahashi ,   K. ,  Y.    Sawasaki ,   J.    Hata ,   K.    Mukai ,  and   T.    Goto .   1990 .   Spontaneous 
transformation and immortalization of human endothelial cells.       In Vitro 
Cell. Dev. Biol.     26 : 265  –  274 .    
   Tsukamoto ,   T. ,  and   S.K .   Nigam .   1997 .   Tight  junction  proteins  form  large  com-
plexes and associate with the cytoskeleton in an ATP depletion model for 
reversible junction assembly.       J. Biol. Chem.     272 : 16133  –  16139 .    
   Tsukita ,   S. ,   M.    Furuse ,  and   M.    Itoh .   2001 .   Multifunctional  strands  in  tight  junc-
tions.     Nat. Rev. Mol. Cell Biol.     2 : 285  –  293 .    
   Vasioukhin ,   V. ,   C.    Bauer ,   M.    Yin ,  and   E.    Fuchs .   2000 .   Directed  actin  polym-
erization is the driving force for epithelial cell-cell adhesion.       Cell   .  
 100 : 209  –  219 .                